Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action.
about
The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes.Attenuated Suppression of Lipolysis Explains Increases in Triglyceride Secretion and Concentration with Basal Insulin Peglispro (BIL) Relative to Insulin Glargine Treatment in Patients with Type 1 Diabetes.Dose Unit Establishment for a New Basal Insulin Using Joint Modeling of Insulin Dose and Glycemic Response.Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes.Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8Novel hepato-preferential basal insulin peglispro (BIL) does not differentially affect insulin sensitivity compared with insulin glargine in patients with type 1 and type 2 diabetes.Open-label, randomized study comparing basal insulin peglispro and insulin glargine, in combination with oral antihyperglycemic medications, in insulin-naïve Asian patients with type 2 diabetes.
P2860
Q33771752-A0BA612E-1D76-4F21-95BD-D852B95D58E4Q38620136-AA804AC5-CC17-481C-B635-0137E713FAABQ38807485-B39E1FF4-A0DC-4FBF-93C3-A0F20164F188Q38833207-C7E82FF1-4B47-4A11-BA2A-080E2C6130FFQ41494572-E34BD849-CD31-4578-B4E7-5F1A320C3203Q46001828-11157E86-A4EA-41BE-A25A-D9DC047884FFQ49365317-23058123-7CDC-4CCA-AD0E-3D4266A8CB98
P2860
Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Basal insulin peglispro: Overv ...... a hepato-preferential action.
@en
Basal insulin peglispro: Overv ...... a hepato-preferential action.
@nl
type
label
Basal insulin peglispro: Overv ...... a hepato-preferential action.
@en
Basal insulin peglispro: Overv ...... a hepato-preferential action.
@nl
prefLabel
Basal insulin peglispro: Overv ...... a hepato-preferential action.
@en
Basal insulin peglispro: Overv ...... a hepato-preferential action.
@nl
P2093
P2860
P356
P1476
Basal insulin peglispro: Overv ...... a hepato-preferential action.
@en
P2093
H Linnebjerg
M J Prince
M L Hartman
S J Jacober
P2860
P356
10.1111/DOM.12744
P478
18 Suppl 2
P577
2016-10-01T00:00:00Z